APTEVO THERAPEUTICS INC. — Net Income by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/5a566431-c6bb-490b-9224-067e808b91ca/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-26.0M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-126278 |
| FY 2024 | $-24.1M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-020467 |
| FY 2023 | $-17.4M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-025428 |
| FY 2022 | $8.0M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-010757 |
| FY 2021 | $-28.5M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-011575 |
| FY 2020 | $-17.8M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-016875 |
| FY 2019 | $-40.4M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-012791 |
| FY 2018 | $-53.7M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-008184 |
| FY 2017 | $7.0M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-005384 |
| FY 2016 | $-112.4M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-005738 |
| FY 2015 | $-59.3M | 2015-01-01 – 2015-12-31 | evidence 0001564590-17-005738 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
APTEVO THERAPEUTICS INC. — all facts · Revenue · Operating Income